Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
Semaglutide, a glucagonlike peptide-1 receptor agonist (GLP-1RA), has recently been implicated in cases of nonarteritic anterior ischemic optic neuropathy (NAION), raising safety concerns in the treatment of type 2 diabetes (T2D). To investigate the potential association between semaglutide and NAIO...
Saved in:
| Published in: | JAMA ophthalmology Vol. 143; no. 4; p. 304 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.04.2025
|
| Subjects: | |
| ISSN: | 2168-6173, 2168-6173 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!